Arrios Pharmaceuticals Private Limited

Arrios Pharmaceuticals Private Limited - business services in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2018PTC327888 Incorporated 02 January 2018 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company business services MSME · Micro
Revenue · FY 2025
₹15.9 Lakh
▼ 41% YoY
Net loss · FY 2025
₹1.09 Lakh
Net margin -6.8%
EBITDA · FY 2025
-₹1.09 Lakh
EBITDA margin -6.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Arrios Pharmaceuticals Private Limited

Data last updated:

Arrios Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 02 January 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC327888. Its GSTIN is 07AAQCA3860M1Z5 (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amita Sharma and Jyoti.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 84 Dsidc Centre Kotla Mubarak Pur, New Delhi, Delhi, India – 110003.

As per the financials filed for FY 2025, the company reported a revenue of ₹15.9 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹1.09 Lakh (net margin -6.8%) and EBITDA of -₹1.09 Lakh (EBITDA margin -6.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.

Arrios Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0015979).

Company details

CIN U74999DL2018PTC327888
Registration Number 327888
Incorporation Date 02 January 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0015979

Recognitions & Rankings of Arrios Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-01-0015979

Contact details

Arrios Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    84 Dsidc Centre Kotla Mubarak Pur, New Delhi, Delhi, India – 110003
  • Industry
    Business Services, Miscellaneous Business Activities, Other Services

To see the full contact details of Arrios Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Arrios Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Arrios Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Arrios Pharmaceuticals Private Limited, buy the company report.

Financials of Arrios Pharmaceuticals Private Limited

FY 2025 filings available

Arrios Pharmaceuticals Private Limited reported revenue of ₹15.9 Lakh (down 41% YoY) for FY 2025.

Revenue · FY 2025
₹15.9 Lakh ▼ 41%
Net loss · FY 2025
₹1.09 Lakh margin -6.8%
EBITDA · FY 2025
-₹1.09 Lakh margin -6.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 41%
3 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▼ 147%
3 years · compounded
▲ 56%
5 years · compounded
▼ 56%

Revenue fell 41% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 147% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.09 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.09 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-6.8%
Net Profit Margin-6.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arrios Pharmaceuticals Private Limited, buy the company report.

Board of directors of Arrios Pharmaceuticals Private Limited

Arrios Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Amita SharmaAdditional Director18 Oct 20215 Years 0 MonthsCurrent
JyotiAdditional Director19 Feb 20224 Years 8 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arrios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Arrios Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAQCA3860M1Z5DelhiActive10 May 2018

To see the full GST registrations and return filing status of Arrios Pharmaceuticals Private Limited, buy the company report.

Recent activity

Arrios Pharmaceuticals Private Limited has 10 board changes on record since 2018: 6 appointments and 4 cessations. The latest: Amit Sharma ceased to be Director on 06 Jun 2025.

AGM
Arrios Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Amit Sharma ceased to be Director.
Filing
Arrios Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Jyoti was appointed as Additional Director.
Appointed
Amita Sharma was appointed as Additional Director.
Ceased
Lalit Panwar ceased to be Director.
Ceased
Nitin Kamboj ceased to be Director.
Ceased
Rajeev Kumar ceased to be Director.
Appointed
Amit Sharma was appointed as Director.
Appointed
Lalit Panwar was appointed as Director.
Appointed
Nitin Kamboj was appointed as Director.
Appointed
Rajeev Kumar was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Arrios Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 02 January 2018 (8+ years old) and is registered under CIN U74999DL2018PTC327888.

Arrios Pharmaceuticals has 2 current directors:

The latest financial statements of Arrios Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Arrios Pharmaceuticals is 07AAQCA3860M1Z5, registered in Delhi.

The CIN (Corporate Identification Number) of Arrios Pharmaceuticals is U74999DL2018PTC327888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arrios Pharmaceuticals was incorporated on 02 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

Amit Sharma ceased to be Director on 06 Jun 2025. Jyoti was appointed as Additional Director on 19 Feb 2022. Amita Sharma was appointed as Additional Director on 18 Oct 2021. Arrios Pharmaceuticals has 10 board changes on record in total.

Yes, Arrios Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0015979).

The registered office of Arrios Pharmaceuticals is at 84 Dsidc Centre Kotla Mubarak Pur, New Delhi, Delhi, India – 110003.

Arrios Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.